Get started
Author

Adam Kiljańczyk

A Liquid Biopsy in Bladder Cancer—The Current Landscape in Urinary Biomarkers
2022 · Milena Matuszczak, Adam Kiljańczyk, et al. · International Journal of Molecular Sciences · 65
PDF
Antioxidant Properties of Zinc and Copper—Blood Zinc-to Copper-Ratio as a Marker of Cancer Risk BRCA1 Mutation Carriers
2024 · Milena Matuszczak, Adam Kiljańczyk, et al. · Antioxidants · 26
Surgical Approach in Metastatic Renal Cell Carcinoma: A Literature Review
2023 · Milena Matuszczak, Adam Kiljańczyk, et al. · Cancers · 25
PDF
Correlation between Selenium and Zinc Levels and Survival among Prostate Cancer Patients
2024 · Sandra Pietrzak, Wojciech Marciniak, et al. · Nutrients · 18
PDF
Zinc and Its Antioxidant Properties: The Potential Use of Blood Zinc Levels as a Marker of Cancer Risk in BRCA1 Mutation Carriers
2024 · Milena Matuszczak, Adam Kiljańczyk, et al. · Antioxidants · 16
Pro/antioxidant status and selenium, zinc and arsenic concentration in patients with bipolar disorder treated with lithium and valproic acid
2024 · Joanna Rog, Łukasz Łobejko, et al. · Frontiers in Molecular Neuroscience · 14
PDF
Blood molybdenum level as a marker of cancer risk on BRCA1 carriers
2024 · Milena Matuszczak, Adam Kiljańczyk, et al. · Hereditary Cancer in Clinical Practice · 13
PDF
Blood Lead Level as Marker of Increased Risk of Ovarian Cancer in BRCA1 Carriers
2024 · Adam Kiljańczyk, Milena Matuszczak, et al. · Nutrients · 12
The Role of Focal Therapy and Active Surveillance for Small Renal Mass Therapy
2022 · Milena Matuszczak, Adam Kiljańczyk, et al. · Biomedicines · 10
PDF
Blood Lead (Pb) Levels as a Possible Marker of Cancer Risk in a Prospective Cohort of Women with Non-Occupational Exposure
2025 · Krzysztof Lubiński, Marcin R. Lener, et al. · Biomedicines · 9
PDF
Epigenetic and Liquid Biopsy Biomarkers in Prostate Cancer: Bridging Tumor Heterogeneity and Clinical Implementation
2026 · Joanna Robaczyńska, Maciej Maj, et al. · Cancers · 7
PDF
Cobalt Serum Level as a Biomarker of Cause-Specific Survival among Prostate Cancer Patients
2024 · Sandra Pietrzak, Wojciech Marciniak, et al. · Cancers · 7
Blood and Serum Se and Zn Levels and 10-Year Survival of Patients after a Diagnosis of Kidney Cancer
2024 · Elżbieta Złowocka-Perłowska, Piotr Baszuk, et al. · Biomedicines · 6
Blood Iodine as a Potential Marker of the Risk of Cancer in BRCA1 Carriers
2024 · Adam Kiljańczyk, Milena Matuszczak, et al. · Nutrients · 5
Combined Effects of Selenium, Arsenic, and CAT rs1001179 Genotype on Cancer Risk in Women with Familial Breast Cancer Predisposition
2026 · Jan Lubiński, Antoni Morawski, et al. · Preprints.org
The Potential Role of Vitamin D in BRCA1 Pathogenic Variant Carriers: A Narrative Review
2026 · Joanna Robaczyńska, Milena Kiljańczyk, et al. · International Journal of Molecular Sciences
All-Cause Mortality and Cancer Risk Dependent on Blood Se Level and HRG rs10770 Genotypes on a Prospective Cohort of Women with Familial Breast Cancers
2026 · Krzysztof Lubiński, Adam Stachowski, et al. · International Journal of Molecular Sciences
PDF
Evidence for Genotype-Specific Optimal Blood Lead Levels for Cancer Risk: MKI67 rs11016073 and APOB rs1367117 in a Female Prospective Cohort
2026 · Krzysztof Lubiński, Wojciech Marciniak, et al. · International Journal of Molecular Sciences
PDF
Primary and metastatic brain tumours in hereditary cancer syndromes: case reports with and literature review
2026 · Joanna Robaczyńska, Milena Kiljańczyk, et al. · Hereditary Cancer in Clinical Practice
Serum Iodine Levels and 8-Year Survival in Patients After Kidney Cancer Diagnosis
2025 · Elżbieta Złowocka-Perłowska, Piotr Baszuk, et al. · Cancers
PDF
Works count: 20
Citation count: 233
H-index: 9
I10-index: 9
Year
Topic
Type